| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| visual-representatio..> | 2023-02-02 16:20 | 5.8K | ||
| types-of-treatments-..> | 2023-02-02 16:20 | 7.1K | ||
| treatment-approach.html | 2023-02-02 16:20 | 5.8K | ||
| topical-treatments-f..> | 2023-02-02 16:20 | 7.9K | ||
| testing-recommendati..> | 2023-02-02 16:20 | 5.4K | ||
| style.css | 2023-02-02 16:20 | 53K | ||
| step-care-mangement-..> | 2023-02-02 16:20 | 5.7K | ||
| step-care-management..> | 2023-02-02 16:20 | 8.9K | ||
| psychosocial-health-..> | 2023-02-02 16:20 | 6.7K | ||
| proven-strategies.html | 2023-02-02 16:20 | 5.7K | ||
| prevalence-of-ad.html | 2023-02-02 16:20 | 6.2K | ||
| long-term-efficacy-i..> | 2023-02-02 16:20 | 4.8K | ||
| js/ | 2023-02-02 16:20 | - | ||
| images/ | 2023-02-02 16:20 | - | ||
| home.html | 2023-02-02 16:20 | 55K | ||
| efficacy-in-reducing..> | 2023-02-02 16:20 | 6.1K | ||
| efficacy-in-qol-impr..> | 2023-02-02 16:20 | 6.2K | ||
| efficacy-in-pruritus..> | 2023-02-02 16:20 | 6.0K | ||
| efficacy-in-global-a..> | 2023-02-02 16:20 | 5.6K | ||
| economic-burden-of-a..> | 2023-02-02 16:20 | 5.4K | ||
| dupilumab-trial-find..> | 2023-02-02 16:20 | 12K | ||
| dupilumab-phase.html | 2023-02-02 16:20 | 5.5K | ||
| css/ | 2023-02-02 16:20 | - | ||
| considerations-in-pr..> | 2023-02-02 16:20 | 5.3K | ||
| biologic-and-small-m..> | 2023-02-02 16:20 | 8.3K | ||
| audio/ | 2023-02-02 16:20 | - | ||
| ad-pathophysiology.html | 2023-02-02 16:20 | 4.6K | ||
| __MACOSX/ | 2023-02-02 16:20 | - | ||